Drug–Target Association Kinetics in Drug Discovery
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Jiangsu Province
Publisher
Elsevier BV
Subject
Molecular Biology,Biochemistry
Reference88 articles.
1. Trial watch: phase II failures: 2008-2010;Arrowsmith;Nat. Rev. Drug Discov.,2011
2. An analysis of the attrition of drug candidates from four major pharmaceutical companies;Waring;Nat. Rev. Drug Discov.,2015
3. International Union of Pharmacology Committee on receptor nomenclature and drug classification. XXXVIII. Update on terms and symbols in quantitative pharmacology;Neubig;Pharmacol. Rev.,2003
4. The drug-target residence time model: a 10-year retrospective;Copeland;Nat. Rev. Drug Discov.,2016
5. The added value of assessing ligand-receptor binding kinetics in drug discovery;Guo;ACS Med. Chem. Lett.,2016
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. TAT-W61 peptide attenuates neuronal injury through blocking the binding of S100b to the V-domain of Rage during ischemic stroke;Journal of Molecular Medicine;2023-12-05
2. Mechanistic insights into ligand dissociation from the SARS-CoV-2 spike glycoprotein;2023-11-30
3. High-throughput analysis system of interaction kinetics for data-driven antibody design;Scientific Reports;2023-11-21
4. Cross-view contrastive representation learning approach to predicting DTIs via integrating multi-source information;Methods;2023-10
5. The translational value of ligand‐receptor binding kinetics in drug discovery;British Journal of Pharmacology;2023-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3